These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 25285458)
41. Subdiaphragmatic vagotomy promotes tumor growth and reduces survival via TNFα in a murine pancreatic cancer model. Partecke LI; Käding A; Trung DN; Diedrich S; Sendler M; Weiss F; Kühn JP; Mayerle J; Beyer K; von Bernstorff W; Heidecke CD; Keßler W Oncotarget; 2017 Apr; 8(14):22501-22512. PubMed ID: 28160574 [TBL] [Abstract][Full Text] [Related]
42. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. Wang HH; McIntosh AR; Hasinoff BB; Rector ES; Ahmed N; Nance DM; Orr FW Cancer Res; 2000 Oct; 60(20):5862-9. PubMed ID: 11059784 [TBL] [Abstract][Full Text] [Related]
43. In vivo selection of a highly metastatic cell line from a human pancreatic carcinoma in the nude mouse. Vezeridis MP; Tzanakakis GN; Meitner PA; Doremus CM; Tibbetts LM; Calabresi P Cancer; 1992 Apr; 69(8):2060-3. PubMed ID: 1544114 [TBL] [Abstract][Full Text] [Related]
44. [Suppression of tumor growth in the liver by cis-diamminedichloroplatinum as large oligolamellar liposomes prepared by freezing and thawing]. Kaledin VI; Nikolin VP; Popova NA; Budker VG; Semenova LA Vopr Onkol; 1989; 35(5):599-602. PubMed ID: 2741430 [TBL] [Abstract][Full Text] [Related]
45. Development of an orthotopic syngeneic murine model of colorectal cancer for use in translational research. Evans JP; Winiarski BK; Sutton PA; Ressel L; Duckworth CA; Pritchard DM; Palmer DH; Goldring CE; Kitteringham NR Lab Anim; 2019 Dec; 53(6):598-609. PubMed ID: 30760081 [TBL] [Abstract][Full Text] [Related]
46. Efficacy of oncolytic reovirus against liver metastasis from pancreatic cancer in immunocompetent models. Himeno Y; Etoh T; Matsumoto T; Ohta M; Nishizono A; Kitano S Int J Oncol; 2005 Oct; 27(4):901-6. PubMed ID: 16142304 [TBL] [Abstract][Full Text] [Related]
47. Colonization characteristics of a murine mammary tumor cell line that metastasizes frequently to the heart. Hossain A; Sarkar NH Clin Exp Metastasis; 1991; 9(4):351-61. PubMed ID: 1868627 [TBL] [Abstract][Full Text] [Related]
48. [The studies on the blood supply of metastatic liver tumor induced by VX2 using BrdU]. Shioaki Y; Taniguchi H; Ito A; Daido T; Kiyoki T Nihon Shokakibyo Gakkai Zasshi; 1989 Feb; 86(2):281. PubMed ID: 2754836 [No Abstract] [Full Text] [Related]
49. An animal model for colon cancer metastasis: establishment and characterization of murine cell lines with enhanced liver-metastasizing ability. Bresalier RS; Hujanen ES; Raper SE; Roll FJ; Itzkowitz SH; Martin GR; Kim YS Cancer Res; 1987 Mar; 47(5):1398-406. PubMed ID: 3028609 [TBL] [Abstract][Full Text] [Related]
50. [Establishment of hepatic metastatic subline of nasopharyngeal carcinoma cell line]. Han C; Wang S; Liu L; Yao KT Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):654-7. PubMed ID: 16762876 [TBL] [Abstract][Full Text] [Related]
51. Vaccination with dendritic cells inhibits the growth of hepatic metastases in B6 mice. DeMatos P; Abdel-Wahab Z; Vervaert C; Seigler HF Cell Immunol; 1998 Apr; 185(1):65-74. PubMed ID: 9636684 [TBL] [Abstract][Full Text] [Related]
52. Therapy of murine liver metastases by administration of MDP encapsulated in liposomes. Daemen T; Dontje BH; Veninga A; Scherphof GL; Oosterhuis WL Sel Cancer Ther; 1990; 6(2):63-71. PubMed ID: 2367753 [TBL] [Abstract][Full Text] [Related]
53. Human and murine Kupffer cell function may be altered by both intrahepatic and intrasplenic tumor deposits. Meterissian S; Steele GD; Thomas P Clin Exp Metastasis; 1993 Mar; 11(2):175-82. PubMed ID: 8444009 [TBL] [Abstract][Full Text] [Related]
54. Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2. Lafreniere R; Rosenberg SA Cancer Res; 1985 Aug; 45(8):3735-41. PubMed ID: 3893689 [TBL] [Abstract][Full Text] [Related]
56. Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer. Yan Y; Rubinchik S; Wood AL; Gillanders WE; Dong JY; Watson DK; Cole DJ Mol Ther; 2006 Feb; 13(2):357-65. PubMed ID: 16226492 [TBL] [Abstract][Full Text] [Related]
57. Re-expression of reduced VEGF activity in liver metastases of experimental pancreatic cancer. Fukuhara M; Uchida E; Tajiri T; Aimoto T; Naito Z; Ishiwata T J Nippon Med Sch; 2005 Jun; 72(3):155-64. PubMed ID: 16046832 [TBL] [Abstract][Full Text] [Related]
58. The role of angiogenesis in endocrine liver metastases: an experimental study. Pourreyron C; Poncet G; Roche C; Gouysse G; Nejjari M; Walter T; Villaume K; Jacquier MF; Bernard C; Dumortier J; Chayvialle JA; Bachelot T; Scoazec JY J Surg Res; 2008 Jan; 144(1):64-73. PubMed ID: 17643449 [TBL] [Abstract][Full Text] [Related]
59. Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control. Jimenez RE; Hartwig W; Antoniu BA; Compton CC; Warshaw AL; Fernández-Del Castillo C Ann Surg; 2000 May; 231(5):644-54. PubMed ID: 10767785 [TBL] [Abstract][Full Text] [Related]